Pacer Advisors Inc. Has $9.60 Million Stake in The Cigna Group (NYSE:CI)

Pacer Advisors Inc. increased its stake in The Cigna Group (NYSE:CI) by 61.5% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 34,773 shares of the health services provider’s stock after acquiring an additional 13,241 shares during the quarter. Pacer Advisors Inc.’s holdings in The Cigna Group were worth $9,602,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of CI. ORG Wealth Partners LLC acquired a new position in The Cigna Group during the fourth quarter worth $34,000. Ulland Investment Advisors LLC increased its position in shares of The Cigna Group by 2,500.0% during the third quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock worth $36,000 after acquiring an additional 100 shares in the last quarter. Prospera Private Wealth LLC acquired a new stake in shares of The Cigna Group in the 3rd quarter worth about $37,000. Harbor Capital Advisors Inc. bought a new position in The Cigna Group in the 3rd quarter valued at about $45,000. Finally, Intact Investment Management Inc. acquired a new position in The Cigna Group during the 3rd quarter valued at about $69,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on CI. Truist Financial dropped their target price on The Cigna Group from $420.00 to $390.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Cantor Fitzgerald restated an “overweight” rating and set a $400.00 price objective on shares of The Cigna Group in a research note on Wednesday, October 23rd. Deutsche Bank Aktiengesellschaft reduced their target price on shares of The Cigna Group from $398.00 to $394.00 and set a “buy” rating for the company in a research note on Monday, November 4th. Barclays raised their price target on shares of The Cigna Group from $405.00 to $420.00 and gave the company an “overweight” rating in a research report on Tuesday, November 5th. Finally, Royal Bank of Canada decreased their price objective on shares of The Cigna Group from $384.00 to $377.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. One investment analyst has rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Buy” and an average target price of $395.93.

The Cigna Group Price Performance

CI opened at $303.49 on Thursday. The firm has a 50-day moving average price of $296.45 and a 200-day moving average price of $325.14. The Cigna Group has a twelve month low of $262.03 and a twelve month high of $370.83. The company has a quick ratio of 0.72, a current ratio of 0.72 and a debt-to-equity ratio of 0.71. The company has a market capitalization of $84.42 billion, a price-to-earnings ratio of 28.63, a PEG ratio of 0.78 and a beta of 0.54.

The Cigna Group (NYSE:CI) last issued its earnings results on Thursday, October 31st. The health services provider reported $7.51 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.22 by $0.29. The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. The business had revenue of $63.70 billion for the quarter, compared to analysts’ expectations of $59.58 billion. During the same quarter in the previous year, the firm posted $6.77 EPS. The business’s revenue for the quarter was up 29.8% compared to the same quarter last year. Equities analysts expect that The Cigna Group will post 28.5 EPS for the current year.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.